![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Off-the-Shelf Allogeneic CAR-T Cells or Other Immune Effector Cells
“Off-the-shelf” allogeneic CAR TCRab T cells and other immune effector cells, such as natural killer (NK) or gamma delta (gd) T cells, can be premanufactured from healthy donors and may offer alternatives to a...
-
Article
Open AccessBase-edited CAR T cells for combinational therapy against T cell malignancies
Targeting T cell malignancies using chimeric antigen receptor (CAR) T cells is hindered by ‘T v T’ fratricide against shared antigens such as CD3 and CD7. Base editing offers the possibility of seamless disrup...
-
Article
Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency
-
Article
Gene Therapy for Primary Immunodeficiencies: Current Status and Future Prospects
Gene therapy using autologous haematopoietic stem cells offers a valuable treatment option for patients with primary immunodeficiencies who do not have access to an HLA-matched donor, although such treatments ...